Smartwatch + App Monitoring for Medication Adherence in HIV
(USE-MI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to test the USE-MI system hardware and software to see if it can accurately measure when subjects take their HIV-related medications and help them remember to take these medications. With the use of a smartwatch and smartphone "app", investigators hope to be able to monitor medication adherence in real-time and send subjects electronic reminders when they may have forgotten to take their medication.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since the study aims to monitor medication adherence, it seems likely that you will continue taking your current HIV-related medications.
Is the Smartwatch + App Monitoring for Medication Adherence in HIV safe for humans?
How is the USE-MI System treatment different from other treatments for HIV?
What data supports the effectiveness of the USE-MI treatment for medication adherence in HIV?
Research shows that using technology like apps and sensors can help people with HIV stick to their medication schedule. For example, a study found that real-time monitoring and reminders improved medication adherence in HIV patients, suggesting that similar systems like USE-MI could be effective.12578
Who Is on the Research Team?
Barry Saver, MD
Principal Investigator
Swedish Medical Center
Jenna Marquard, PhD
Principal Investigator
University of Massachusetts, Amherst
Are You a Good Fit for This Trial?
This trial is for individuals with HIV on antiretroviral therapy (ART) or those at risk taking PrEP. Participants must manage their own medication, use pill bottles the USE-MI system can monitor, speak English reasonably well, and attend monthly follow-ups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot Phase
Initial testing of the USE-MI system with 10 subjects for feedback
Main Evaluation Phase
Up to 50 subjects use the USE-MI system to assess accuracy, robustness, and acceptability
Follow-up
Participants are monitored for system acceptability and medication adherence
What Are the Treatments Tested in This Trial?
Interventions
- USE-MI System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Swedish Medical Center
Lead Sponsor
University of Massachusetts, Amherst
Collaborator
University of Washington
Collaborator
National Institute of Mental Health (NIMH)
Collaborator